Broadcom and Apple have extended their chip supply agreement through 2031, locking in a multi-year revenue stream for AVGO's custom silicon business. The deal cements AVGO's position as Apple's primary custom chip partner and adds visibility to an already-strong revenue trajectory growing at nearly 24% YoY.
Broadcom and Apple have extended their chip supply agreement through 2031, locking in a multi-year revenue stream for AVGO's custom silicon business.
AVGO and AAPL have locked in a supply deal through 2031 — the question is whether this extension is priced into AVGO's already-elevated valuation or adds a meaningful new leg of upside from AI-category silicon.
If analyst notes reveal the deal covers only legacy RF components with flat or declining per-unit economics, the extension carries little incremental revenue upside and the initial pop fades. AVGO also trades at a premium multiple, so any broader semis selloff compresses the setup quickly.
CoverageSource: Yahoo Finance · Published here WED, JUL 8 · 6:49 AM ET · 7 outlets in this record · latest listed: Investing.com at 6:49 AM ETHow this is decided →
Broadcom and Apple have agreed to extend their existing chip supply deal through 2031, extending a partnership that covers custom silicon components — likely including RF chips and potentially custom AI/networking silicon — used across Apple's product lineup. The extension adds roughly six more years of contracted revenue visibility to Broadcom's already robust top line, which hit $63.9B in FY2025 at nearly 24% YoY growth.
For Broadcom, the deal matters because Apple represents one of its largest single customers, and multi-year supply agreements of this length are rare. AVGO's 67.8% gross margin profile underscores how lucrative these custom silicon engagements are, and locking in Apple through 2031 reduces the key-customer concentration risk that has historically been a bear overhang.
For Apple, the extension signals continued reliance on Broadcom for components it either cannot or has chosen not to fully internalize, despite its aggressive in-house chip strategy. AAPL's 6.4% revenue growth is solid but modest, and maintaining a long-term supply relationship with a trusted partner reduces supply-chain disruption risk heading into its next product cycles.
The second-order question is whether this deal signals Broadcom is also embedded in Apple's AI ambitions — custom AI inference chips or networking silicon would carry higher ASPs and margin than legacy RF components. If that's the case, the revenue visibility from this extension could be meaningfully larger than prior contract cycles.
What to watch: any analyst updates quantifying the deal's annual revenue contribution to AVGO, and whether Apple discloses further detail about the chip categories covered in the extension — those two data points would substantially tighten the valuation case.
A six-year supply extension with Apple anchors revenue visibility for AVGO at a time when its top line is already compounding at ~24% YoY with 67.8% gross margins. The deal reduces key-customer concentration uncertainty and, if it includes AI-category silicon, could imply meaningfully higher future ASPs. The concrete hook is incremental de-risking of the revenue base, not a surprise rerating event.
The read above, as written. kept as written · closes shown from JUL 8 on
4-8 weeks, into next AVGO earnings. Follow to be told when one lands.
Price context does not establish that the story caused the move.
Broadcom's 67.8% gross margin on $63.9B in FY2025 revenue — growing 24% YoY — gains a hard revenue floor through 2031 if AI-category silicon is included, supporting a premium multiple that analysts have struggled to derate.
If the deal covers only legacy RF and wireless components where pricing is flat-to-declining, the extension adds duration but not incremental earnings power, leaving AVGO's elevated valuation exposed to any growth-rate deceleration in its AI networking segment.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →
This page is kept as it was written on Jul 8. Later coverage joins it only when the company and catalyst evidence match, and what the stock did is shown from licensed end-of-day closes — never re-graded, never backdated. The judgment is yours.